Blueprint starts with getting to know the company, existing shareholders and understanding management's long-term vision. Working with the board of directors, senior management and in-house investor relations teams, we develop an Investor Relations strategy that is in line with company goals. We then execute this strategy by organizing the events, developing the collateral material and introducing management to the appropriate fund managers and research analysts. We will also provide feedback and market intelligence on the specific areas of focus along with industry and investor sentiment – important in understanding the overall market and driving forward with a plan that bolsters the profile among investors. Blueprint also offers a 12 month pre-IPO program focused on generating early awareness and establishing traction. An integral part of our program is drafting a post transaction investor relations/corporate communications strategy, focused on expanding institutional ownership, liquidity, and securing a fundamental presence in the mainstream life science investment and business communities.